TrialThe Journal of antimicrobial chemotherapy2017

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.

Thomas P C Dorlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.